UK markets closed

Olema Pharmaceuticals, Inc. (OLMA)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
9.95+0.12 (+1.22%)
At close: 04:00PM EDT
9.52 -0.43 (-4.32%)
After hours: 07:14PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
0
Operating expenses
Research development
86,140
86,140
82,274
51,100
13,704
Selling general and administrative
18,821
18,821
24,714
20,391
7,824
Total operating expenses
104,961
104,961
106,988
71,491
21,528
Operating income or loss
-104,961
-104,961
-106,988
-71,491
-21,528
Interest expense
-
-
-
0
653
Total other income/expenses net
-19
-19
-27
-47
-
Income before tax
-96,655
-96,655
-104,787
-71,096
-22,121
Income from continuing operations
-96,655
-96,655
-104,787
-71,096
-22,121
Net income
-96,655
-96,655
-104,787
-71,096
-22,121
Net income available to common shareholders
-96,655
-96,655
-104,787
-71,096
-23,990
Basic EPS
-2.31
-
-2.62
-1.80
-3.42
Diluted EPS
-2.31
-
-2.62
-1.80
-3.42
Basic average shares
41,548
-
39,995
39,524
7,021
Diluted average shares
41,548
-
39,995
39,524
7,021